SVLCX
Price
$32.56
Change
-$0.14 (-0.43%)
Updated
Aug 15 closing price
Net Assets
2.43B
VIVAX
Price
$70.33
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

SVLCX vs VIVAX

Header iconSVLCX vs VIVAX Comparison
Open Charts SVLCX vs VIVAXBanner chart's image
Columbia Select Large Cap Value C
Price$32.56
Change-$0.14 (-0.43%)
VolumeN/A
Net Assets2.43B
Vanguard Value Index I
Price$70.33
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
SVLCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SVLCX vs. VIVAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVLCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. SVLCX (2.43B). VIVAX pays higher dividends than SVLCX: VIVAX (2.06) vs SVLCX (0.99). SVLCX was incepted earlier than VIVAX: SVLCX (26 years) vs VIVAX (33 years). SVLCX (1.83) is less costly to investors than VIVAX (0.17). SVLCX is a more actively managed with annual turnover of: 20.00 vs. VIVAX (9.00). SVLCX has a lower initial minimum investment than VIVAX: SVLCX (2000) vs VIVAX (3000). SVLCX annual gain was more profitable for investors over the last year : 10.41 vs. VIVAX (8.04). VIVAX return over 5 years is better than : 68.78 vs. SVLCX (55.32).
SVLCXVIVAXSVLCX / VIVAX
Total Expense Ratio1.550.17912%
Annual Report Gross Expense Ratio1.830.171,076%
Fund Existence26 years33 years-
Gain YTD11.1116.648167%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.43B196B1%
Annual Yield % from dividends0.992.0648%
Returns for 1 year10.418.04130%
Returns for 3 years25.7426.0999%
Returns for 5 years55.3268.7880%
Returns for 10 years65.17114.9157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGOTX79.92N/A
N/A
Hartford Growth Opportunities R5
LGOAX42.73N/A
N/A
Patient Opportunity A
PQNAX26.13N/A
N/A
Virtus NFJ Mid-Cap Value A
TVOIX39.76N/A
N/A
Touchstone Small Cap Value Institutional
PAIOX8.19N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps R6